Recent Changes in Drug Abuse Scenario: The Novel Psychoactive Substances (NPS) Phenomenon
In parallel with a decrease/stabilization in the use of internationally controlled drugs, the market of novel psychoactive substances (NPS) continues increasing, year after year, with the Internet playing a pivotal role in contributing to this complex scenario. At times, although misleading, the ter...
Saved in:
: | |
---|---|
Year of Publication: | 2019 |
Language: | English |
Physical Description: | 1 electronic resource (198 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993548088804498 |
---|---|
ctrlnum |
(CKB)4920000000094853 (oapen)https://directory.doabooks.org/handle/20.500.12854/57762 (EXLCZ)994920000000094853 |
collection |
bib_alma |
record_format |
marc |
spelling |
Fabrizio Schifano (Ed.) auth Recent Changes in Drug Abuse Scenario: The Novel Psychoactive Substances (NPS) Phenomenon Recent Changes in Drug Abuse Scenario MDPI - Multidisciplinary Digital Publishing Institute 2019 1 electronic resource (198 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier In parallel with a decrease/stabilization in the use of internationally controlled drugs, the market of novel psychoactive substances (NPS) continues increasing, year after year, with the Internet playing a pivotal role in contributing to this complex scenario. At times, although misleading, the terms ‘legal highs’ or ’research chemicals’ have been used to describe these molecules. Overall, about 5% of 19–24-year-old European people have already experimented with them, because both NPS’ intense psychoactive effects and their virtual non-detectability in routine drug screenings. Although ‘novel’ typically refers to molecules that have recently become a reason of current/potential public health concern, at times, the NPS scenario may indeed focus on pharmaceutical molecules. These may have either not entered the market, or are currently prescribed, with their potential for misuse resulting from the relating high dosages/idiosyncratic ways of self-administration. A concurrent use of a range of different NPS, and/or medications, is frequently being reported and this may be a reason of further clinical complications. Given their complex pharmacodynamics, there are increasing levels of concern about the onset of acute/chronic psychopathological associated with NPS intake. This Special Issue aims at providing an overview of a range of NPS-related issues, e.g., preclinical, epidemiological, and clinical pharmacological; the medical and psychopathological consequences associated with their intake; and, finally, the analytical chemistry and forensic analysis challenges associated with the NPS phenomenon. English NPS drug abuse/misuse novel psychoactive substances prescribing drugs’ misuse 3-03897-507-9 |
language |
English |
format |
eBook |
author |
Fabrizio Schifano (Ed.) |
spellingShingle |
Fabrizio Schifano (Ed.) Recent Changes in Drug Abuse Scenario: The Novel Psychoactive Substances (NPS) Phenomenon |
author_facet |
Fabrizio Schifano (Ed.) |
author_variant |
f s e fse |
author_sort |
Fabrizio Schifano (Ed.) |
title |
Recent Changes in Drug Abuse Scenario: The Novel Psychoactive Substances (NPS) Phenomenon |
title_full |
Recent Changes in Drug Abuse Scenario: The Novel Psychoactive Substances (NPS) Phenomenon |
title_fullStr |
Recent Changes in Drug Abuse Scenario: The Novel Psychoactive Substances (NPS) Phenomenon |
title_full_unstemmed |
Recent Changes in Drug Abuse Scenario: The Novel Psychoactive Substances (NPS) Phenomenon |
title_auth |
Recent Changes in Drug Abuse Scenario: The Novel Psychoactive Substances (NPS) Phenomenon |
title_alt |
Recent Changes in Drug Abuse Scenario |
title_new |
Recent Changes in Drug Abuse Scenario: The Novel Psychoactive Substances (NPS) Phenomenon |
title_sort |
recent changes in drug abuse scenario: the novel psychoactive substances (nps) phenomenon |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
publishDate |
2019 |
physical |
1 electronic resource (198 p.) |
isbn |
3-03897-508-7 3-03897-507-9 |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT fabrizioschifanoed recentchangesindrugabusescenariothenovelpsychoactivesubstancesnpsphenomenon AT fabrizioschifanoed recentchangesindrugabusescenario |
status_str |
n |
ids_txt_mv |
(CKB)4920000000094853 (oapen)https://directory.doabooks.org/handle/20.500.12854/57762 (EXLCZ)994920000000094853 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Recent Changes in Drug Abuse Scenario: The Novel Psychoactive Substances (NPS) Phenomenon |
_version_ |
1792839734374957056 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02736nam-a2200325z--4500</leader><controlfield tag="001">993548088804498</controlfield><controlfield tag="005">20231214133307.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202102s2019 xx |||||o ||| 0|eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3-03897-508-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4920000000094853</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/57762</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994920000000094853</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Fabrizio Schifano (Ed.)</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Recent Changes in Drug Abuse Scenario: The Novel Psychoactive Substances (NPS) Phenomenon</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Recent Changes in Drug Abuse Scenario</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (198 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In parallel with a decrease/stabilization in the use of internationally controlled drugs, the market of novel psychoactive substances (NPS) continues increasing, year after year, with the Internet playing a pivotal role in contributing to this complex scenario. At times, although misleading, the terms ‘legal highs’ or ’research chemicals’ have been used to describe these molecules. Overall, about 5% of 19–24-year-old European people have already experimented with them, because both NPS’ intense psychoactive effects and their virtual non-detectability in routine drug screenings. Although ‘novel’ typically refers to molecules that have recently become a reason of current/potential public health concern, at times, the NPS scenario may indeed focus on pharmaceutical molecules. These may have either not entered the market, or are currently prescribed, with their potential for misuse resulting from the relating high dosages/idiosyncratic ways of self-administration. A concurrent use of a range of different NPS, and/or medications, is frequently being reported and this may be a reason of further clinical complications. Given their complex pharmacodynamics, there are increasing levels of concern about the onset of acute/chronic psychopathological associated with NPS intake. This Special Issue aims at providing an overview of a range of NPS-related issues, e.g., preclinical, epidemiological, and clinical pharmacological; the medical and psychopathological consequences associated with their intake; and, finally, the analytical chemistry and forensic analysis challenges associated with the NPS phenomenon.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NPS</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drug abuse/misuse</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">novel psychoactive substances</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">prescribing drugs’ misuse</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03897-507-9</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2024-03-07 03:45:16 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2019-11-10 04:18:40 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338699160004498&Force_direct=true</subfield><subfield code="Z">5338699160004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338699160004498</subfield></datafield></record></collection> |